Duodenoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2034

Duodenoscopes Market Summary

Overview:

• The Duodenoscopes market is estimated at USD 280 million in 2025 and is projected to reach USD 440 million by 2034. Growth is anchored in the rising burden of pancreaticobiliary disease, the growing volume of endoscopic retrograde cholangiopancreatography procedures, and the transition toward single-use and disposable-component designs driven by infection-control concerns.
• The global Duodenoscopes market is growing at a CAGR of 5.2% during the forecast period from 2026 to 2034.
• By product type, the reusable duodenoscopes segment dominated the Duodenoscopes market with a 55% share in 2025.
• By application, the treatment segment dominated the Duodenoscopes market with a share of 78% in 2025.
• By end-user, the hospitals segment dominated the Duodenoscopes market with a share of 75% in 2025.
• North America dominated the global Duodenoscopes market revenue with a share of 40% in 2025, representing the highest regional market share globally.

Duodenoscopes are specialized flexible endoscopes used to access the duodenum and the pancreaticobiliary system, primarily to perform endoscopic retrograde cholangiopancreatography for the diagnosis and treatment of conditions of the bile ducts and pancreas. Featuring a side-viewing design and an elevator mechanism that directs instruments and devices, duodenoscopes are used for therapeutic interventions such as stone removal, stenting, and management of strictures and leaks, as well as diagnostic procedures. The category is divided by product type into reusable duodenoscopes, including conventional fixed-endcap designs and newer designs with disposable distal caps or elevators, and single-use, fully disposable duodenoscopes. These devices are supplied by leading endoscopy companies including Olympus, FUJIFILM, and PENTAX Medical in reusable systems, and Boston Scientific and Ambu in single-use systems, along with Karl Storz and others. Duodenoscopes are used across treatment and diagnostic applications, in hospitals and diagnostic and endoscopy centers. Over the past decade, the field has been reshaped by concerns about device-associated infections linked to the difficulty of reprocessing reusable duodenoscopes, prompting regulatory action and a transition toward disposable distal caps and fully single-use designs. Driven by the rising burden of pancreaticobiliary disease, growing procedure volumes, and the infection-control-driven shift to disposable designs, duodenoscopes are an important and steadily evolving segment of the endoscopy market.

Duodenoscopes Market Key Growth Drivers

• The rising burden of pancreaticobiliary disease, including gallstones, bile duct and pancreatic disorders, and related cancers, is expanding demand for duodenoscopes.
• The growing volume of endoscopic retrograde cholangiopancreatography procedures is driving demand for therapeutic and diagnostic duodenoscopes.
• Infection-control concerns and regulatory action regarding reprocessing of reusable duodenoscopes are driving the transition to disposable distal caps and single-use designs.
• The launch and adoption of single-use, fully disposable duodenoscopes, led by Boston Scientific and Ambu, are reshaping the market and driving premium growth.
• Technological advances, including improved imaging, ergonomics, and disposable-component designs, are improving safety and adoption.
• The aging population and expanding endoscopy capacity and access, particularly in emerging markets, are broadening demand.
• The convergence of rising pancreaticobiliary disease, procedure growth, and the infection-control-driven shift to disposable designs is expected to sustain steady growth in the global Duodenoscopes market through 2034.

Key Companies in Duodenoscopes Market

The competitive landscape is led by the following active developers and manufacturers of duodenoscopes:

• Olympus Corporation
• FUJIFILM Holdings Corporation
• Boston Scientific Corporation
• PENTAX Medical (HOYA Corporation)
• Ambu A/S
• KARL STORZ SE & Co. KG
• Medtronic plc
• Cook Medical LLC
• Micro-Tech Endoscopy
• SonoScape Medical Corp.

Factors Contributing to the Growth of the Duodenoscopes Market

Market Drivers

Rising Burden of Pancreaticobiliary Disease

The rising burden of pancreaticobiliary disease is the foundational driver of the duodenoscopes market. Conditions of the bile ducts and pancreas, including gallstones and choledocholithiasis, biliary strictures, pancreatitis, bile duct and pancreatic cancers, and related disorders, are common and rising with aging, obesity, and other risk factors, and their diagnosis and treatment frequently require endoscopic retrograde cholangiopancreatography performed with a duodenoscope. The growing prevalence of gallstone disease and pancreaticobiliary cancers expands the population requiring these procedures, and duodenoscopes are essential, specialized tools for accessing and treating the pancreaticobiliary system. As the burden of pancreaticobiliary disease continues to rise, demand for duodenoscopes continues to grow, reinforcing sustained market growth throughout the forecast period.

Growing Volume of ERCP Procedures

The growing volume of endoscopic retrograde cholangiopancreatography procedures is a defining driver of the duodenoscopes market. Endoscopic retrograde cholangiopancreatography is the primary procedure performed with duodenoscopes and has become the standard, minimally invasive approach for treating many pancreaticobiliary conditions, including stone removal, stenting of strictures, and management of leaks and obstructions. The rising number of these procedures, driven by the growing burden of pancreaticobiliary disease, aging populations, and expanding access to advanced endoscopy, directly increases demand for duodenoscopes. The predominantly therapeutic nature of these procedures sustains high utilization of duodenoscopes in hospitals and endoscopy centers. As procedure volumes continue to grow, this trend is expected to be a leading driver of duodenoscope demand across the forecast period.

Market Restraints

Despite steady momentum, the Duodenoscopes market faces material constraints. The specialized and relatively narrow clinical use of duodenoscopes, confined largely to endoscopic retrograde cholangiopancreatography, limits the absolute size of the market compared with broader endoscopy segments. The high per-procedure cost of single-use duodenoscopes, relative to the amortized cost of reusable devices, constrains adoption in cost-sensitive settings, and environmental and waste considerations associated with disposables add concerns. Reusable duodenoscopes face ongoing challenges and costs related to complex reprocessing, infection-control compliance, repair, and the risk of residual contamination, and the transition to disposable-component and single-use designs imposes replacement and purchasing costs on facilities. The procedures require highly trained endoscopists and specialized infrastructure, and a shortage of advanced endoscopists and limited access to therapeutic endoscopy constrain procedure volumes, particularly in emerging markets. Rigorous and evolving regulatory requirements and reprocessing standards add cost and complexity, and regulatory scrutiny of reusable devices continues. Market concentration among a few large manufacturers and long device lifecycles for reusable systems can affect dynamics. Finally, uneven endoscopy infrastructure and affordability constraints in emerging markets can restrict adoption across parts of the forecast period.

Duodenoscopes Market Segment Analysis

The Duodenoscopes Market is segmented by product type (reusable duodenoscopes, single-use duodenoscopes), application (treatment, diagnostics), end-user (hospitals, diagnostic and endoscopy centers, others), and geography (North America, Europe, Asia-Pacific, Rest of World).

By Product Type

Dominant Subsegment: Reusable Duodenoscopes.

The reusable duodenoscopes segment accounted for 55% of the Duodenoscopes market in 2025. Reusable duodenoscopes dominate because they represent the large established installed base and the majority of procedures, are offered by the leading endoscopy manufacturers Olympus, FUJIFILM, and PENTAX Medical, and remain widely used across hospitals and endoscopy centers. Reusable systems, increasingly incorporating disposable distal caps and elevators to improve reprocessing and reduce contamination risk, retain the largest share of the market by value in 2025. However, the single-use, fully disposable duodenoscopes segment, led by Boston Scientific's EXALT Model D and Ambu's single-use duodenoscope, is the fastest-growing segment and is strategically favored, driven by infection-control concerns, regulatory guidance recommending a transition away from fixed-endcap reusable designs, and the elimination of reprocessing. The single-use segment is capturing a growing share, particularly for high-risk patients and safety-focused settings, and the link indicates rising single-use demand. Nonetheless, the large installed base and continued use of reusable duodenoscopes, now often with disposable components, secure the leadership of this segment by current share across the forecast period, even as single-use designs grow most rapidly and reshape the market.

By Application

Dominant Subsegment: Treatment.

The treatment segment accounted for 78% of the Duodenoscopes market in 2025. The treatment, or therapeutic, application dominates because duodenoscopes are used overwhelmingly for therapeutic endoscopic retrograde cholangiopancreatography, including the removal of bile duct stones, placement of biliary and pancreatic stents, management of strictures, sphincterotomy, and treatment of leaks and obstructions. Endoscopic retrograde cholangiopancreatography has evolved into a predominantly therapeutic procedure, as less invasive imaging methods such as magnetic resonance cholangiopancreatography and endoscopic ultrasound have largely replaced purely diagnostic endoscopic retrograde cholangiopancreatography, concentrating duodenoscope use in therapeutic interventions. This drives the overwhelming share of duodenoscope procedures and demand. The diagnostic application, while reduced by the availability of non-invasive imaging, remains relevant for specific cases requiring direct visualization, tissue sampling, or combined diagnosis and treatment. Nonetheless, the predominance of therapeutic endoscopic retrograde cholangiopancreatography secures the leadership of the treatment segment across the forecast period.

Duodenoscopes Market Region Analysis

North America accounted for 40% of the global Duodenoscopes market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced endoscopy infrastructure, high procedure volumes, early and strong adoption of single-use and disposable-component duodenoscopes driven by infection-control concerns, and the presence of leading manufacturers. The United States leads on the strength of a large advanced endoscopy and hospital network, high volumes of endoscopic retrograde cholangiopancreatography, and the strongest response to duodenoscope-associated infection concerns, having been the center of the regulatory action and outbreaks that drove the transition to safer designs, and the presence of major players including Boston Scientific with the EXALT Model D single-use duodenoscope. The regulatory environment is well established, with the Food and Drug Administration having issued guidance recommending the transition away from fixed-endcap reusable duodenoscopes, accelerating adoption of disposable-component and single-use designs. Strong infrastructure and infection-control focus further reinforce the market. This combination of infrastructure, procedure volumes, and leadership in the transition to safer designs reinforces North America's leadership in the global market.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Duodenoscopes market. The region's elevated CAGR is driven by large populations, a rising burden of pancreaticobiliary disease, expanding advanced endoscopy capacity, and growing healthcare access across China, Japan, India, South Korea, and Southeast Asia. Rising prevalence of gallstone disease and pancreaticobiliary disorders, aging populations in several countries, and increasing access to therapeutic endoscopy expand demand for duodenoscopes and endoscopic retrograde cholangiopancreatography, and growing healthcare investment and the expansion of endoscopy training and infrastructure broaden procedure volumes. China and other countries are expanding advanced endoscopy capacity, and domestic manufacturers such as Micro-Tech and SonoScape are expanding endoscopy offerings. Both multinational and regional manufacturers are expanding their presence, and interest in single-use designs is growing. The combination of large populations, rising disease burden, expanding endoscopy access, and growing capacity positions Asia-Pacific as the highest-growth region over the forecast period.

Regional Commentary

North America

North America accounted for 40% of the global Duodenoscopes market revenue in 2025. The United States dominates the region on the strength of advanced endoscopy infrastructure, high procedure volumes, and leadership in the transition to single-use and disposable-component duodenoscopes following infection concerns, while Canada and Mexico contribute through their healthcare systems and expanding access.

Europe

Europe represents the second-largest regional market, led by Germany, France, the United Kingdom, and Italy. Growth is supported by established endoscopy infrastructure, high procedure volumes, and adoption of disposable-component and single-use designs, and the presence of manufacturers such as Karl Storz and Ambu, while the European Medical Device Regulation and reprocessing standards shape the market.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by large populations, a rising burden of pancreaticobiliary disease, expanding advanced endoscopy capacity, and growing healthcare access across China, Japan, India, South Korea, and Southeast Asia. Expanding endoscopy training, domestic manufacturing, and growing access are broadening adoption.

Rest of World

The Rest of World region, spanning the Middle East, Africa, and South America, is an emerging growth frontier. A rising burden of pancreaticobiliary disease, improving endoscopy infrastructure, and expanding access to therapeutic endoscopy are broadening adoption from a developing base, while investment in advanced endoscopy supports growth.

Duodenoscopes Market Competitive Landscape

The Duodenoscopes market is classified as Consolidated. A small group of companies holds the majority of revenue, led by the established endoscopy leaders Olympus, FUJIFILM, and PENTAX Medical in reusable duodenoscopes, and Boston Scientific and Ambu in single-use duodenoscopes, while Karl Storz, Medtronic, Cook Medical, and regional manufacturers such as Micro-Tech and SonoScape compete across the market.

The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Consolidated, with reusable duodenoscopes led by a few established endoscopy companies and single-use duodenoscopes led by a small number of innovators.
• Leading players: Olympus, FUJIFILM, and PENTAX Medical lead reusable duodenoscopes, while Boston Scientific and Ambu lead single-use duodenoscopes, with Karl Storz, Medtronic, Cook Medical, Micro-Tech, and SonoScape competing across segments and regions.
• Geographic reach: Leaders operate global commercial and manufacturing networks, with strong positions across North America, Europe, and Asia-Pacific.
• Product portfolio strength: Players hold reusable duodenoscopes with disposable distal caps, single-use duodenoscopes, and broader endoscopy and ERCP device portfolios.
• Pipeline strength: Development focuses on single-use designs, disposable components, improved imaging, and ergonomics.
• Strategic partnerships: Collaborations with hospitals and endoscopy centers and responses to regulatory guidance shape the competitive landscape.
• M&A activity: Portfolio shifts and investment focus on single-use and disposable-component technologies.
• Manufacturing capabilities: Specialized endoscope manufacturing and, for single-use, scalable disposable production are key competitive strengths.
• Innovation focus: Single-use and fully disposable duodenoscopes, disposable distal caps and elevators, improved imaging, and infection-control-driven design.

Duodenoscopes Market Recent Developmental Activities

In 2023 and 2024, Boston Scientific expanded adoption of its EXALT Model D single-use duodenoscope, the first fully disposable duodenoscope, driven by infection-control concerns. Strategic significance: Advances the single-use transition and reshapes the competitive landscape.

In 2023 and 2024, Ambu expanded its single-use duodenoscope offering, strengthening the disposable segment. Strategic significance: Intensifies competition in single-use duodenoscopes and expands disposable options.

Duodenoscopes Market Segmentation

Duodenoscopes Market by Product Type

• Reusable Duodenoscopes (including Disposable Distal Cap Designs)
• Single-Use (Fully Disposable) Duodenoscopes

Duodenoscopes Market by Application

• Treatment (Therapeutic ERCP)
• Diagnostics

Duodenoscopes Market by End-User

• Hospitals
• Diagnostic and Endoscopy Centers
• Others

Duodenoscopes Market by Geography

• North America Duodenoscopes Market
• United States Duodenoscopes Market Size in USD million (2023-2034)
• Canada Duodenoscopes Market Size in USD million (2023-2034)
• Mexico Duodenoscopes Market Size in USD million (2023-2034)
• Europe Duodenoscopes Market
• Germany Duodenoscopes Market Size in USD million (2023-2034)
• United Kingdom Duodenoscopes Market Size in USD million (2023-2034)
• France Duodenoscopes Market Size in USD million (2023-2034)
• Italy Duodenoscopes Market Size in USD million (2023-2034)
• Spain Duodenoscopes Market Size in USD million (2023-2034)
• Rest of Europe Duodenoscopes Market Size in USD million (2023-2034)
• Asia-Pacific Duodenoscopes Market
• China Duodenoscopes Market Size in USD million (2023-2034)
• Japan Duodenoscopes Market Size in USD million (2023-2034)
• India Duodenoscopes Market Size in USD million (2023-2034)
• Australia Duodenoscopes Market Size in USD million (2023-2034)
• South Korea Duodenoscopes Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Duodenoscopes Market Size in USD million (2023-2034)
• Rest of the World (RoW) Duodenoscopes Market
• Middle East Duodenoscopes Market Size in USD million (2023-2034)
• Africa Duodenoscopes Market Size in USD million (2023-2034)
• South America Duodenoscopes Market Size in USD million (2023-2034)

Key Takeaways from the Duodenoscopes Market Report Study

• Market size analysis for the current duodenoscopes market size (2025), and market forecast for 9 years (2026 to 2034).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
• Key companies dominating the global duodenoscopes market.
• Various opportunities available for competitors in the duodenoscopes market space.
• What are the top-performing segments in 2025? How will these segments perform in 2034?
• Which are the top-performing regions and countries in the current duodenoscopes market scenario?
• Which are the regions and countries where companies should concentrate their opportunities for duodenoscopes market growth in the future?

Target audience who can benefit from this duodenoscopes market report study

• Duodenoscopes product providers
• Research organizations and consulting companies
• Duodenoscopes-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in duodenoscopes
• Various end-users who want to know more about the duodenoscopes market and the latest technological developments in the duodenoscopes market.

Frequently Asked Questions:

Q1. What is the growth rate of the Duodenoscopes market?

The Duodenoscopes market is projected to expand at a CAGR of 5.2% during the forecast period of 2026-2034.

Q2. What is the market size of the Duodenoscopes market?

The Duodenoscopes market is estimated at USD 280 million in 2025 and is projected to reach USD 440 million by 2034.

Q3. Which region dominates the Duodenoscopes market?

North America dominated the Duodenoscopes market with a 40% share of global revenue in 2025, supported by advanced endoscopy infrastructure, high procedure volumes, leadership in the transition to single-use and disposable-component designs, supportive FDA guidance, and the presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Duodenoscopes market?

The principal drivers are the rising burden of pancreaticobiliary disease; the growing volume of endoscopic retrograde cholangiopancreatography procedures; infection-control concerns and regulatory action driving the transition to disposable-component and single-use designs; and the adoption of single-use duodenoscopes, reinforced by technological advancement and the aging population and expanding endoscopy access.

Q5. Who are the major players in the Duodenoscopes market?

The major players include Olympus Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, PENTAX Medical (HOYA Corporation), Ambu A/S, KARL STORZ SE & Co. KG, Medtronic plc, Cook Medical LLC, Micro-Tech Endoscopy, and SonoScape Medical Corp., among other active manufacturers profiled in the Competitive Landscape section. Olympus, FUJIFILM, and PENTAX Medical lead reusable duodenoscopes, while Boston Scientific and Ambu lead single-use duodenoscopes.